Ordinary Index Rebalancing in the Solactive Transatlantic Healthcare Equity Index | April 2022

In the ordinary rebalance the following composition will be implemented effective open 08.04.2022:

ABBOTT LABORATORIES
ABBVIE INC
AGILENT TECHNOLOGIES INC
ALCON INC
AMGEN INC
ANTHEM INC
BAXTER INTL.
BAYER AG
BECTON DICKINSON AND CO
BOSTON SCIENTIFIC CORP
BRISTOL-MYERS SQUIBB CO
CHEMED CORP
CIGNA CORP
COLOPLAST AS CLASS B
COOPER COMPANIES INC
DANAHER CORP
DAVITA INC
DENTSPLY SIRONA INC
ELI LILLY & CO
EMBECTA CORP ORD
FRESENIUS MEDICAL CARE AG & CO KGAA
GILEAD SCIENCES INC
HOLOGIC INC
HORIZON THERAPEUTICS PLC
ICU MEDICAL INC
INCYTE CORP
INTEGRA LIFESCIENCES HOLDING
IQVIA HOLDINGS INC
IRONWOOD PHARMACEUTICALS INC
JOHNSON & JOHNSON
LABORATORY CRP OF AMER HLDGS
MEDTRONIC PLC
MERCK & CO. INC.
METTLER-TOLEDO INTL
NOVARTIS AG
PRESTIGE CONSUMER HEALTHCARE INC
QIAGEN NV
QUEST DIAGNOSTICS INC
RECORDATI SPA
REGENERON PHARMACEUTICALS
ROCHE HOLDING AG
ROYALTY PHARMA PLC- CL A
SANOFI SA
STERIS PLC
STRYKER CORP
THERMO FISHER SCIENTIFIC INC
UCB SA
UNITEDHEALTH GROUP INC
VERTEX PHARMACEUTICALS INC
WATERS CORP
ZOETIS INC